Thursday 24 May 2012

Teva Pharmaceutical Industries Ltd-Medical Device Company-Cancer Pharmaceuticals

InspireMD Announces Enrollment Completion In Master Trial

TEL AVIV, Israel, May 24, 2012 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial... read more..

Nanosmart(R) Pharmaceuticals Welcomes New Vice President Of R&D

ORANGE COUNTY, Calif., May 24, 2012 /PRNewswire/ -- Dr. James Smith, President of NanoSmart Pharmaceuticals, Inc., a California corporation developing a novel drug-delivery platform for cancer pharmaceuticals, announced today that the company has added Dr. Paul Glidden as Vice... read more..

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update

Teva Jumps as New CEO Jeremy Levin Set to Give Guidance Update
Bloomberg - 15 minutes ago
Teva Pharmaceutical Industries Ltd. (TEVA) rose the most in almost two months before new Chief Executive Officer Jeremy Levin gives an update on financial guidance. read more..

1 comment:

  1. I’m satisfied with the information that you provide for me and thanks for this because sometimes people face this problem. Please share these types of information. HEOR Companies